June 21, 2024

AI and Genetic Diseases

McGovern Medical School research employs artificial intelligence to improve the diagnosis and treatment of hereditary conditions such as Marfan syndrome, Loeys-Dietz syndrome, and vascular Ehlers-Danlos syndrome.

June 10, 2024

Beta-blockers may help decrease bone loss in male patients with dementia, according to UTHealth Houston study

Men with dementia who were taking beta-blockers showed a slight decrease in the rate of bone loss compared with men who were not, according to a small observational study led by researchers at UTHealth Houston. Women in the study, published in Calcified Tissue…

April 18, 2024

In Memoriam: Dr. Barbara Murray

Barbara E. Murray, MD, J. Ralph Meadows Professor of Medicine in the Division of Infectious Diseases, Department of Internal Medicine, died April 11, 2024. She was 76. A member of the Medical School’s ID faculty since 1980, she was a…

October 3, 2023

Researchers uncover why a gene mutant causes young children to have strokes

A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD, with UTHealth Houston, insight into understanding the cause of a rare and progressive problem with arteries in the brain and a cause…

June 23, 2023

UTHealth Houston researcher awarded over $5M to study and improve the diagnostic process in clinics to prevent errors

Improving the diagnostic process and preventing errors are the focus of two studies funded by the U.S. Department of Health and Human Services (HHS) and led by Eric Thomas, MD, associate dean for health care quality with McGovern Medical School at UTHealth…

August 30, 2022

Awake prone positioning does not offer benefit in reducing intubation for COVID-19 induced acute respiratory failure

A large multicenter, randomized clinical trial revealed no difference in the risk of endotracheal intubation requirement at 30 days between awake prone positioning and standard positioning for patients with COVID-19 who suffered from acute hypoxemic respiratory failure, according to research…

June 21, 2022

Targeting a specific protein in smooth muscle cells may dramatically reduce atherosclerotic plaque formation

A new study shows targeting a protein in smooth muscle cells can block and decrease buildup of atherosclerotic plaque in mouse models, according to researchers with UTHealth Houston. The study was published today in Arteriosclerosis, Thrombosis, and Vascular Biology. Atherosclerosis…